adverse-event

Documents about adverse-event

• The impact of critical incidents on nurses and midwives: A systematic review#197581Research Online
• SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)#353281ClinicalTrials.gov
• Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification#912869ClinicalTrials.gov
• Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia#967305ClinicalTrials.gov
• Venous thromboembolism with combined oral contraceptives based on estrogen and progestin content: a disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database#159210HAL (France)
• Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary#315162IRIS
• Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma#872481ClinicalTrials.gov
• Clinical Trial of Donepezil Between the Naive Group and the Switching Group#876704ClinicalTrials.gov
• Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension#888115ClinicalTrials.gov
• Safety of COVID-19 mRNA-1273 booster doses in Asian populations: A literature review of post-marketing observational studies#224209Europe PMC
• Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay#904939ClinicalTrials.gov
• TIL and Anti-PD1 in Metastatic Melanoma#1009054ClinicalTrials.gov
• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma#208453ClinicalTrials.gov
• The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use#804176ClinicalTrials.gov
• Characterization of Arrhythmia-induced Cardiomyopathy#810946ClinicalTrials.gov
• FLUAD® vs. Fluzone® High-Dose Study#897186ClinicalTrials.gov
• Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.#907700ClinicalTrials.gov
• Improving entity recognition using ensembles of deep learning and fine-tuned large language models: A case study on adverse event extraction from VAERS and social media.#9223NCBI PubMed Central
• Moving on after critical incidents in health care. Second victims: A qualitative study of the experiences of nurses and midwives#197578Research Online
• Interactive Digital Health Tools to Improve Patient Safety in Acute Care#833970ClinicalTrials.gov
• Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific#846729ClinicalTrials.gov
• VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines#172266Springer Nature OA
• Moving on after critical incidents in health care: A qualitative study of the perspectives and experiences of second victims#197579Research Online
• Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes#853022ClinicalTrials.gov
• Impact of COVID-19 Vaccines on Cerebrovascular Health#916525ClinicalTrials.gov
• Aspirin Resistance and Percutaneous Coronary Intervention (PCI)#894959ClinicalTrials.gov
• Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation#223136OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)#871397ClinicalTrials.gov
• Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation#855605ClinicalTrials.gov
• Study to Improve Survival Among HIV-Exposed Infants in Botswana#906904ClinicalTrials.gov
• Table 1_Post-marketing safety signal profile of mavacamten in the FDA adverse event reporting system (FAERS): a disproportionality analysis.docx#669803Figshare
• Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide#834478ClinicalTrials.gov
• Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database#172253Springer Nature OA
• Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers#870274ClinicalTrials.gov
• a Single-arm, Single-center, Open Clinical Study#916801ClinicalTrials.gov
• Evaluation of a nurse-led program for the prevention of complications of long-term glucocorticoids (COCORTICO): study protocol for a randomized trial#442517HAL (France)
• Feasibility and Tolerance of High-Intensity Interval Training in Adults With Cystic Fibrosis#424880HAL (France)
• Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event#857835ClinicalTrials.gov
• Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome#831357ClinicalTrials.gov
• STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump#880968ClinicalTrials.gov
• Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties#28871HAL (France)
• Safety,Effectiveness and Acceptability of Sino-implant II in DR#804296ClinicalTrials.gov
• Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV#853451ClinicalTrials.gov